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Abstract
Several reports have recently contributed to determine the effector inventory of the sequenced strain Pseudomonas syringae
pv. phaseolicola (Pph) 1448a. However, the contribution to virulence of most of these effectors remains to be established.
Genetic analysis of the contribution to virulence of individual P. syringae effectors has been traditionally hindered by the
lack of phenotypes of the corresponding knockout mutants, largely attributed to a high degree of functional redundancy
within their effector inventories. In support of this notion, effectors from Pseudomonas syringae pv. tomato (Pto) DC3000
have been classified into redundant effector groups (REGs), analysing virulence of polymutants in the model plant Nicotiana
benthamiana. However, using competitive index (CI) as a virulence assay, we were able to establish the individual
contribution of AvrPto1PtoDC3000 to Pto DC3000 virulence in tomato, its natural host, even though typically, contribution to
virulence of AvrPto1 is only shown in strains also lacking AvrPtoB (also called HopAB2), a member of its REG. This report
raised the possibility that even effectors targeting the same defence signalling pathway may have an individual contribution
to virulence, and pointed out to CI assays as the means to establish such a contribution for individual effectors. In this work,
we have analysed the individual contribution to virulence of the majority of previously uncharacterised Pph 1448a effectors,
by monitoring the development of disease symptoms and determining the CI of single knockout mutants at different stages
of growth within bean, its natural host. Despite their potential functional redundancy, we have found individual
contributions to virulence for six out of the fifteen effectors analysed. In addition, we have analysed the functional
relationships between effectors displaying individual contribution to virulence, highlighting the diversity that these
relationships may present, and the interest of analysing their functions within the context of the infection.
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Introduction
Pseudomonas syringae is a gram-negative host-specific pathogen
that depends on the Hrp type III secretion system (T3SS) to
secrete and translocate effector proteins into the plant cell, thus
causing disease in compatible hosts, and triggering a hypersensitive
response (HR) in incompatible hosts [1]. The specificity of the
T3SS-mediated plant-pathogen interaction is based on the set of
effectors translocated by each strain [2]. Although the T3SS is
essential for P. syringae infection, mutation of individual effectors
has rarely succeeded in revealing virulence attenuation [3–7].
Frequently, reports showing effector contribution to virulence
have resorted to the use of multiple effector mutants [8–10]. Thus,
functional redundancy between effectors has been repeatedly
proposed as the determining factor hindering the detection of
virulence phenotypes for single effector mutants. In support of this
notion, functional characterisation has already revealed seemingly
similar defence suppressing capabilities for many P. syringae
effectors [11]. In some cases, such as that of effectors AvrPto1
and AvrPtoB (now also called HopAB2) from P. syringae pv. tomato
DC3000 (hereafter referred to as Pto DC3000), studies have
demonstrated that the same defence signalling pathway is targeted
by both effectors [12,13]. In keeping with this, recent studies have
classified the effectors from this strain into redundant effector
groups (REGs), and established a minimal effector repertoire of
eight as enough to render a functionally effectorless Pto DC3000
derivative, capable of full growth within the model plant N.
benthamiana [10,14]. On the other hand, virulence assays with
higher sensitivity than standard assays, i.e. competitive index assays
(CIs), have allowed detection of virulence phenotypes for single
effector mutants such as AvrPto1 [15,16].
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35871In this work, we have carried out an extensive analysis of the
effector inventory of the P. syringae pv. phaseolicola 1448a strain
(hereafter Pph 1448a), using a collection of single effectors mutants
previously generated by our team [17]. We have analysed
symptom development for each strain, as well as growth in mixed
infection (CI) at different stages after infiltration into Phaseolus
vulgaris (common bean), its natural host. When CIs were used, we
detected reproducible virulence phenotypes for six out of the
fifteen single effector mutant strains analysed. Only one of these
mutants was also accompanied by a delay in induction of disease
symptoms. The virulence attenuation of the mutants can be
complemented by expression of the corresponding effector from a
plasmid. However, we also show that overexpression of some of
these effectors can be detrimental for wild type growth. We also
carried out CI assays following dip-inoculation into bean leaves for
several of the mutant strains, obtaining very similar results to those
generated using infiltration. Furthermore, we have analysed the
functional relationships between effectors displaying individual
contribution to virulence, applying a conceptual modification of
CI analysis, the cancelled-out index or COI, to carry out genetic
analysis of single and double mutants. COI analysis were
previously developed for such purpose in animal pathogens [18],
and have already been applied in P. syringae to establish functional
relationships between regulatory elements of the type III secretion
system [19,20], and between plant defence signalling cascades
triggered by heterologous effectors [21,22].
Results
Development of symptoms by individual effector
knockout mutants
P. syringae effectors are usually named as defined by the unified
effector nomenclature [23], specifying the strain of origin as a sub-
index after the effector name (e.g. HopR1Pph1448a). However, to
avoid unnecessary repetitions, the name of the strain will only be
specified when effectors from different strains are mentioned in the
same context, using just the name of the effector when the strain of
origin has been already stated.
We used a collection of fifteen mutants of P. syringae pv.
phaseolicola (Pph) 1448a generated in our laboratory (Table 1) [17]
to monitor the development of symptoms throughout time,
following leaf infiltration. The mutant collection included thirteen
effector mutants, and a mutant in avrD1, an HrpL-dependent gene
encoding the enzyme syringolide [24], for which translocation
through the T3SS is unclear [25,26]). It also includes two genes
currently considered to encode helper proteins that may or may
not be translocated [27–29]. Only one effector knockout, DhopR1,
displayed a sustained and reproducible reduction in the induction
of disease symptoms in bean leaves whereas the rest either
displayed no differences with the wild type strain, or differences
too subtle or variable to be established with confidence (Table 2
and Figure 1). The absence of a virulence phenotype for the
majority of the single mutants in these assays is in keeping with
results obtained in previous analysis of single effector mutants in P.
syringae strains [3–7].
Quantification of bacterial populations within infected
bean plants
Once inside compatible hosts, P. syringae strains replicate rapidly
in the apoplastic spaces, leading to the formation of microcolonies
and the development of disease [30]. We selected the most
relevant time points of this process on the basis of a time course
experiment of bean plants (cv. Canadian Wonder) infected with
Pph 1448a either by infiltration with a blunt syringe, or by dipping
the leaves into a bacterial suspension. We included as a non-
pathogenic control a DhrpL-mutant derivative of Pph 1448a [31],
which lacks HrpL, an essential transcriptional regulator of
virulence functions, including the T3SS [32–34]. We inoculated
the plants by either infiltrating with 5610
4 cfu/ml, or dipping into
a5 610
7 cfu/ml bacterial suspension, in order to achieve an initial
population of approximately 1000 cfu per plant one hour after
inoculation (t0), regardless of the inoculation procedure applied. In
the case of Pph 1448a, bacterial numbers increased rapidly up to 7
days post-inoculation (dpi), after which the population remained
stable up to 14 dpi, with the full onset of symptoms taking place
between 10 to 12 dpi (Figure 2 and data not shown). The DhrpL
mutant strain reached its highest populations by 7 dpi, a
population 100 to 1000-fold smaller than wild type, and decayed
later 5 to 50-fold, depending on the inoculation procedure. As
expected, the maximum size of the bacterial population varied
depending on the inoculation method (10
8 cfu/cm
2 after infiltra-
tion and 5610
6 cfu/cm
2 after dip-inoculation), since following
dippping, pathogen-associated molecular patterns (PAMPs), like
flagellin, are exposed to plant cells before bacteria have reached
the apoplast, where full induction of T3SS expression takes place.
This allows for an earlier and therefore more effective activation of
plant defences using dipping than using infiltration to introduce
bacteria directly into the leaf apoplast [35,36].
Considering these results, we selected for further analysis 4 dpi
as a time point in which wild type populations are rapidly growing,
while populations of the T3SS-defective mutant still display some
growth, and 7 dpi as the time point at which both wild type and
mutant populations are stabilized at their respective the maximum
cfu. In some cases we also sampled at 14 dpi, to analyse bacterial
populations in the context of symptomatic tissue and maximal
difference between wild type and mutant populations.
Several type III effectors from Pph 1448a display reduced
growth in bean plants
We applied CI assays to the fifteen effector mutants analysed for
development of symptoms (Tables 1 and 2) and determined the CI
values at the selected time points after infiltration. Figure 3A shows
the results obtained for eleven of these mutants for which CI were
determined at 4, 7 and 14 dpi. CI values are shown in Table S1.
Five out of them displayed significant virulence attenuation at one
or more time points (DavrB2, DhopAB1, DhopAU1, DhopI1, DhopR1;
Figure 3A). Interestingly, growth attenuation displayed by
DhopAU1 could be detected in fully established populations (7
and 14 dpi), but not at the earliest time point (Figure 3A). The
mutant DhopAS1 strain only displayed CI values lower than 1.0 at
14 dpi (Figure 3A), suggesting a contribution to growth at the end
of the infection process. However, this attenuation was only
statistically significant in two out of three independent experiments
and was therefore close to the limit of confidence. No significant
attenuation was detected for the other five strains (DavrD1,
DhopAE1, DhopAY1, hopAW1, DhopD1; Figure 3A). It should be
mentioned that very small increases in growth (1.3 to 1.5-fold)
were detected for DhopAE1 (14 dpi), DhopAY1 (14 dpi), hopAW1 (4,
7 and 14 dpi), and DhopD1 (4 and 7 dpi) mutant strains, some of
which were statistically significant (DhopD1 at both 4 and 7 dpi).
However, whether these differences are biologically meaningful is
open to question.
The remaining four strains of the collection, DhopG1, DhopQ1,
DhopAJ1 and DhopAK1, were analysed at 4 and 7 dpi, however no
significant attenuation was detected, with only a slight increase in
growth (1.5-fold) detectable by 7 dpi for DhopAJ1 (Figure 3B).
Additionally, we tested whether the phenotype of DhopAB1 and
DhopI1 single mutants, which displayed growth attenuation
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the majority of the single mutants assayed, could be complemented
by plasmid-encoded wild type alleles expressed from the
corresponding native promoters. (Figure 3A). By 4 dpi, none of
the mutants was complemented since the CI of the mutants and
the CI of the mutants carrying the corresponding plasmids were
not statistically different (Figure 4). Similar results were observed
for DhopI1 at 7 dpi, however, the CI of DhopAB1 carrying the
plasmid was significantly higher than that of the mutant strain at
that time point, indicating that attenuation of DhopAB1 was being
complemented. Nevertheless, complementation was not complete
by 7 dpi since the CI of the mutant strain carrying the plasmid was
still lower than 1.0 (Figure 4). By 14 dpi, both DhopAB1 and DhopI1
strains were fully complemented by the ectopic expression of the
corresponding effector, since the CIs of the mutants carrying the
plasmids were not significantly different from 1.0 (Figure 4). All CI
values are shown in Table S1. Prior to using the native promoters,
we attempted complementation of these two mutant strains by
ectopic expression of the effectors from the same vector, but under
the control of the medium-to-low expression PlacZ constitutive
promoter: in these conditions no complementation of bacterial
growth could be detected at any time point (data not shown).
Considering the potential complexities that validating all
attenuated mutant phenotypes through complementation may
present on the basis of the results obtained with DhopAB1 and
DhopI1, we analyzed the phenotypes of independently generated
knockout mutants for avrB2, hopR1, hopAU1, and hopAS1.C I
analysis of all four mutant strains rendered significant attenuations
by late stages of the infection (i.e. 14 dpi), but only those from
mutants avrB2 and hopR1 show significant attenuation by 4 dpi
(data not shown), fully confirming previously determined pheno-
types.
Effector overexpression may reduce bacterial growth in
planta
The mechanisms by which the Pph 1448a effectors analysed
contribute to virulence are yet to be determined, but are likely to
include suppression of host defences, as described for other strains
[37]. Since we found that some of the assayed effectors have a
quantitative contribution to Pph 1448a bacterial growth in planta,
we wondered whether increasing their expression could enhance
defence suppression and result in an increase in bacterial growth
within the plant. We tested HopAB1 and HopI1 since they have
homologues in other P. syringae pathovars with well-characterised
defence suppression capabilities [4,38]. The hopAB1 and hopI1
ORFs were expressed under the control of the strong constitutive
PnptII promoter, from the medium-copy number plasmid pAMEX
[29], the backbone vector used for the complementation assays.
To our surprise, overexpression of either HopAB1 or HopI1 from
Pph 1448a caused a clear reduction of growth within the plant
compared to the wild type (Figure 5). Growth attenuation due to
the overexpression of HopAB1 was specific of growth within the
plant, since the CI assay carried out in rich medium was not
significantly different to 1.0 (Figure 5). However, overexpression of
HopI1 also caused a small reduction in bacterial growth in rich
medium, although in this case the reduction was significantly
Table 1. Bacterial strains used in this work.
Bacterial strain Description Antibiotic resistance Source
P. syringae pv. phaseolicola 1448a Race 6, wild-type strain Nal
r [60]
P. syringae pv. phaseolicola 1449b Race 7, wild-type strain [60]
RW60 1449b derivative, Vir
2, pAV511
2 Rif
r [41]
IOM1 DhrcV Nal
r Km
r [31]
IOM7 DhrpL Nal
r Km
r [31]
AZJ19 DhopAB1::nptII Nal
r Km
r [17]
AZJ21 DavrB2::nptII Nal
r Km
r [17]
AZJ22 DhopR1::nptII Nal
r Km
r [17]
AZJ23 DhopAY1::nptII Nal
r Km
r [17]
AZJ24 DhopAW1::nptII Nal
r Km
r [17]
AZJ25 DhopAS1::nptII Nal
r Km
r [17]
AZJ26 DhopAJ1::nptII Nal
r Km
r [17]
AZJ27 DhopAU1::nptII Nal
r Km
r [17]
AZJ28 DhopAK1::nptII Nal
r Km
r [17]
AZJ29 DhopAE1::nptII Nal
r Km
r [17]
AZJ30 DhopD1::nptII Nal
r Km
r [17]
AZJ31 DhopQ1::nptII Nal
r Km
r [17]
AZJ32 DhopG1::nptII Nal
r Km
r [17]
AZJ33 DhopI1::nptII Nal
r Km
r [17]
AZJ34 DavrD1::nptII Nal
r Km
r [17]
JRP4 DhopAB1 Nal
r This work
AZJ38 DhopAB1 DhopI1::nptII Nal
r Km
r This work
AZJ39 DhopAB1 DhopQ1::nptII Nal
r Km
r This work
AZJ41 DhopAB1 DhopR1::nptII Nal
r Km
r This work
doi:10.1371/journal.pone.0035871.t001
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results suggest a need for a tight regulation of effector expression,
since effectors otherwise contributing to bacterial growth within
the plant may have deleterious effects when expressed beyond
their appropriate levels.
Several effector mutant strains display attenuated
growth after dip inoculation
The activation of plant defences through PAMP recognition
prior to full induction of the T3SS or bacterial entrance through
the stomata determine differences in the pathogen-plant interac-
tion process that may lead to differences in the results obtained
from virulence assays following inoculation by infiltration or by
dipping [35,36]. We selected several effector mutants to carry out
CI analysis by dipping to determine if this inoculation procedure
would lead to different results to those obtained using infiltration.
Mutant strains DavrB2, DavrD1, DhopAB1, DhopAY1, DhopR1, and
DhopI1 were co-inoculated with the wild type by dipping and their
CIs determined. The CIs obtained were very similar to those
obtained using infiltration, except for attenuation of DhopR1 whose
attenuation could no longer be established at the end of the
infection (14 dpi) (Figure 6). All CI values are shown in Table S1.
CI-based analysis of functional relationships between
effectors
Homologues from three out of the four effectors required for
growth throughout the entire course of the infection have defence
suppression activities [4,10,11,39–41] and, as will be discussed, our
virulence assays support similar roles for the corresponding Pph
1448a effectors. This raised the question of whether the virulence
activities of these four effectors could be functionally related. To
established this, we carried out epistasis analysis taking advantage
of a CI modification, the cancelled-out index or COI, originally set
up for such purpose in animal pathogens [18,42–45], and recently
applied to the analysis of structural and regulatory components of
the T3SS in Pph 1448a [19,20], and to that of plant defence
responses against Pto DC3000 expressing heterologous effectors
[21,22]. The question to be answered by COI-based epistasis
analysis was whether the growth attenuation phenotype caused by
DhopAB1 could be detected in the absence of any of the other two
effectors. For that purpose, double mutant strains lacking HopAB1
and each of the other effectors (HopR1, and HopI1) were
generated by introducing the knockout alleles for hopR1 and hopI1
in the DhopAB1 single mutant strain. Double mutant strains were
co-inoculated with each of the corresponding single mutant
strains. The index generated from calculating the double to single
mutant output ratio, divided by the corresponding input ratio, the
cancelled out index, allows direct determination of the phenotype
that mutation of hopAB1 has in the absence of each of the other
effectors (Figure S1). Thus, each of the effectors analysed is missing
both in the single and the double co-inoculated mutants, and its
effect in growth is thus cancelled out in the resulting index. If the
phenotype of DhopAB1 cannot be established in the absence of the
other effectors the resulting COI would be equal to one (Figure
S1). Reversely, if HopAB1 contribution to virulence can be
detected in the absence of the effector tested, DhopAB1 would have
the same phenotype regardless of the genotype of the effector gene
being tested, and the resulting COI would therefore be equal to its
CI (Figure S1). Controls to confirm that both types of results (COI
not significantly different from 1.0 and COI not significantly
different from the CI) could be obtained when analysing effector
mutants with such subtle attenuated phenotypes were carried out
(Figure S2). COI values are shown in Table S1.
COI-based epistasis analysis showed that whereas DhopAB1
phenotype could not be detected when HopR1 was also missing
(COI of DhopAB1 when DhopR1 is cancelled out is not significantly
different from 1.0, Figure 7A), it was fully detected when HopI1
was missing (COI of DhopAB1 when DhopI1 is cancelled out is not
significantly different from the CI of DhopAB1, Figure 7B). Both
results were confirmed by analysing independently generated
double mutant strains (data not shown).
When the reciprocal analyses were carried out, we found that
whereas HopR1 contribution to virulence was independent on the
function of HopAB1, HopI1 contribution was largely independent
from HopAB1 (COI showed a 1.5-fold attenuation versus .3-fold
shown by CI) (Table 3).
Discussion
The individual contribution of T3SS effectors to virulence has
been traditionally difficult to establish in P. syringae, a fact usually
explained by the redundant activities reported for several
functionally characterized effectors [3–7]. However, our previous
results showed that even effectors proven to be functionally
redundant could display an individual contribution to virulence if
sensitive assays such as CI assays were used [15]. Indeed, the use of
CI assays to analyse effector mutants in Pph 1448a has allowed us
to establish a role in virulence for six out of the fifteen effectors
analysed. This represents a higher percentage of effectors with
established individual contributions to virulence within the Pph
1448a effector inventory than any previously studied P. syringae
strain [10,14]. Whether this is due to differences in the
composition of the effector inventories analysed or to the different
methodology used in each study is yet to be determined, although
our previous results with AvrPto1PtoDC3000 [15] supports the latter.
Table 2. Analysis of symptom development after inoculation
with different strains.
Strain Genotype Symptoms Symptoms
7–8 dpi 10–12 dpi
1448a Wild type **** ******
IOM7 DhrcV
AZJ19 DhopAB1 **** ******
AZJ21 DavrB2 **** ND
AZJ22 DhopR1 * ***
AZJ23 DhopAY1 ****(*) ******
AZJ24 DhopAW1 **** ND
AZJ25 DhopAS1 **** ND
AZJ26 DhopAJ1 **** ******
AZJ27 DhopAU1 ***(*) ******
AZJ28 DhopAK1 **** ******
AZJ29 DhopAE1 **** ******
AZJ30 DhopD1 **** ND
AZJ31 DhopQ1 ****(*) ******
AZJ32 DhopG1 **** ******
AZJ33 DhopI1 **** ND
AZJ34 DavrD1a **** ND
(*)Affecting only some of the inoculated leaves. ND indicates time points not
monitored.
ND indicates time points not monitored.
doi:10.1371/journal.pone.0035871.t002
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quite small in laboratory conditions, their relative importance for
the development of disease is likely to be larger in the field, where
conditions are not as favourable for establishing infection as they
are following forced inoculation in the laboratory.
The CI assays carried out in bean allows us to classify Pph 1448a
effectors into three groups: group I effectors, including those
individually required for wild type-like growth throughout the
course of the infection (AvrB2, HopAB1, HopI1, and HopR1);
group II effectors, including those individually necessary for
growth at later stages of the infection (HopAS1 and HopAU1); and
group III including effectors and/or helper proteins not individ-
ually necessary for growth within bean leaves (AvrD1, HopAE1,
HopAY1, HopAW1, HopD1, HopAJ1, HopAK1, HopG1 and
HopQ1).
The absence of a growth attenuation phenotype for mutants of
Group III proteins could be caused by their having completely
redundant activities, such as it is the case for AvrB4-1 and AvrB4-
2, or HopW1-1 and HopW1-2, for which the use of double
Figure 2. Growth curves of Pph 1448a and Pph DhrpL. Bacteria
were inoculated either by infiltration with a bacterial suspension
containing 5610
4 cfu/ml or by dipping into a bacterial suspension
containing 5610
7 cfu/ml. Error bars represent standard error. Smallest
error bars may be covered by the corresponding symbol.
doi:10.1371/journal.pone.0035871.g002
Figure 1. Disease symptoms in bean plants. Plants were infiltrated with 10
6 cfu/ml, and symptoms documented at 7 days post-inoculation (dpi).
A. Virulence symptoms caused by Pph DhopR1 are significantly reduced in relation to wild type (Pph)-induced symptoms. B. Pph DhopAY1 causes
similar symptoms to those induced by wild type (Pph). The experiment was carried out thrice with similar results. Images show representative results.
doi:10.1371/journal.pone.0035871.g001
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[17]. It is also possible that the contribution to virulence of these
proteins is more evident in other host and/or field conditions. To
this regard, direct infiltration into the leaf apoplast could
potentially hinder detection of virulence contribution by bypassing
the initial steps of the natural infection. However the CI analysis
using dip-inoculation of at least two of these effectors (AvrD1 and
HopAY1) did not support this notion. Finally, some of these
effectors could trigger defence responses that could mask their
virulence activities. Our results show that loss of five of the nine
Group III proteins result in enhanced growth, which could
support this notion, however this increase was only statistically
significant for two of the cases and even then the level of
enhancement was so low (1.3 to 1.5-fold) as to be difficult to
establish their biological significance.
Contribution to virulence for group II effectors (HopAU1 and
HopAS1) is only apparent at late and/or very late stages of the
infection process, preventing the mutant populations from
reaching wild type levels. These effectors could be involved in
modifying the apoplast into a replication-permissive niche, where
Figure 3. Competitive Index analysis of Pph 1448a effector mutants. Mutant strains were co-infiltrated with the wild type strain, and samples
were taken at different time points: A. 4, 7 and 14 days post-inoculation (dpi), or B. 4 and 7 dpi. Competitive indices correspond to the mean of two
to four independent experiments with three replicates per experiment. A dashed line corresponding to a CI=0.5 is included for reference. Error bars
represent the standard error. Asterisks indicate results significantly different from one, as established by Student’s t-test (P,0.05). Mean values
marked with the same letter (a or b) indicate results not significantly different from each other, as established by One Way ANOVA and Holm-Sidak
test for multiple comparison or One Way ANOVA on Ranks and Tukey test for multiple comparison when Equal Variance Test failed (P,0.05). Two
asterisks indicate that attenuation was right on the limit of significance in each independent experiment or when results were pulled from
independent experiments.
doi:10.1371/journal.pone.0035871.g003
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defences.
It is noteworthy that whereas effectors belonging to group I are
present in 60% to almost 100% of the phytopathogenic bacterial
strains sequenced to date, those belonging to groups II and III are
only present in 20% to less than 50% of the sequenced strains,
with the exception of HopAE1, HopAJ1, and HopAK1 [46],
although whether HopAJ1 and HopAK1 act as effectors or as
helpers of translocation is still unclear [27–29]. Furthermore, very
little information is available on the virulence or avirulence
activities of Group II and III effectors, whereas homologues for all
four Group I effectors have been characterized to some level,
supporting the relevance of the virulence activities carried out by
effectors from Group I. To this regard, the Pto DC3000
homologue of HopAB1 (also known as AvrPtoBPtoDC3000), the
homologue of HopI1 from P. syringae pv. maculicola (Pma ES4326),
and at least one member of each of the families that form the
AvrE/DspA/E/HopM1/HopR superfamily, have been shown to
promote bacterial growth [4,16,47–51]. The AvrB family has been
reported to have a small but significant contribution to bacterial
growth in compatible interactions and a contribution to leaf
chlorosis in Arabidopsis in the absence of RPM1 recognition,
although whether this chlorosis is the result of virulence or
avirulence activities is still unclear [52–54]. Members of the
HopR1, HopI1 and HopAB1 effector families have all been shown
to have some defence suppression activity. HopR1PtoDC3000, which
displays 85% amino acid identity with its Pph 1448a homologue,
has been shown to function redundantly with other effectors in
promoting bacterial growth by suppressing PAMP-triggered
immunity [10,40]. HopI1PmaES4326 hijacks the plant chaperone
machinery, causing chloroplast thylakoid structure remodelling
and suppressing SA accumulation [4,39]. HopI1Pph1448a shares
68% amino acid identity with HopI1PmaES4326 and although
shorter by virtue of some amino acids missing from its middle
section, still maintains a putative J domain in its C-terminal region
(Figure S3), a domain necessary for HopI1PmaES4326 contribution
to virulence [4]. Finally, HopAB1Pph1449b (formerly VirPphA) was
the first effector for which a virulence activity was demonstrated,
postulated to be suppression of HopF1 (formerly AvrPphF)-
triggered immunity [41]. HopAB1 orthologs from different P.
syringae pathovars have been since described to suppress and/or
trigger defences in different plant species [38,47]. HopAB2P-
toDC3000, also known as AvrPtoBPtoDC3000, harbours a C-terminal
E3 ubiquitin ligase domain [55], which specifically ubiquitinates
the Fen kinase in tomato plants, promoting its proteasome-
dependent degradation [56]. This activity prevents plant defence
activation through the recognition by the Fen kinase of the
HopAB2PtoDC3000 N-terminal domain [56]. HopAB1Pph1448a
amino acid sequence is 100% identical to that from Pph 1449b
strain (data not shown), and both have a predicted E3 ligase C-
terminal domain (Figure S3). Virulence activities similar to those
described by their homologues would explain HopR1, HopI1 and
Figure 4. Complementation analysis of DhopAB1 and DhopI1.
The mutant strains carrying a plasmid expressing the corresponding
effector from their native promoter were co-inoculated with the wild
type strain and samples were taken at different time points (4, 7 and
14 dpi). Competitive indices are the average of three replicates per
experiment. The assays were repeated twice with very similar results.
The CIs of the relevant mutants are included (grey) for comparison
purposes. A dashed line corresponding to a CI=0.5 is included for
reference. Error bars represent the standard error. Asterisks indicate
results significantly different from one, as established by Student’s t-test
(P,0.05). Mean values marked with the same letter (a or b) indicate
results not significantly different from each other, as established by One
Way ANOVA and Holm-Sidak test for multiple comparison (P,0.05).
doi:10.1371/journal.pone.0035871.g004
Figure 5. Effect on bacterial growth of overexpressing HopAB1 and HopI1. Wild type strain Pph 1448a carrying plasmids expressing either
of these effectors from the strong nptII promoter were co-inoculated with the wild type strain. Competitive index was analyzed either in bean leaves
(at 7 dpi) or in rich medium (LB medium, at 24 hours post-inoculation). Competitive indices are the average of three replicates per experiment. A
dashed line corresponding to a CI=0.5 is included for reference. Error bars represent the standard error. Asterisks indicate results significantly
different from one, as established by Student’s t-test (P,0.05). Mean values marked with the same letter (a or b) indicate results not significantly
different from each other, as established by One Way ANOVA and Holm-Sidak test for multiple comparison or One Way ANOVA on Ranks and Tukey
test for multiple comparison when Equal Variance Test failed (P,0.05).
doi:10.1371/journal.pone.0035871.g005
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PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e35871Figure 6. Competitive Index analysis of Pph 1448a effector mutants following dip-inoculation. Mutant strains were co-inoculated with
the wild type strain, and samples were taken at different time points (4, 7 and 14 days post-inoculation, dpi) as indicated. Competitive indices
correspond to the mean of two to three independent experiments with three replicates per experiment. A dashed line corresponding to a CI=0.5 is
included for reference. Error bars represent the standard error. Asterisks indicate results significantly different from one, as established by Student’s t-
test (P,0.05). Mean values marked with the same letter (a or b) indicate results not significantly different from each other, as established by One Way
ANOVA and Holm-Sidak test for multiple comparison (P,0.05).
doi:10.1371/journal.pone.0035871.g006
Figure 7. Cancelled-out index (COI) epistasis analysis of Pph 1448a effectors. Epistasis analysis of HopR1 (A) and HopI1 (B) on the
contribution to virulence of HopAB1. Double mutants strains were co-infiltrated with each single mutant strain and the corresponding COI was
determined at 7 dpi. All relevant CIs are included (grey) for comparison purposes. Each COI corresponds to the mean of at least three independent
experiments with three replicates per experiment. A dashed line corresponding to an index value=0.5 is included for reference. Error bars represent
the standard error. Asterisks indicate results significantly different from one, as established by Student’s t-test (P,0.05). Mean values marked with the
same letter (a or b) indicate results not significantly different from each other, as established by One Way ANOVA and Holm-Sidak test for multiple
comparisons (P,0.05).
doi:10.1371/journal.pone.0035871.g007
Contribution to Virulence of Type III Effectors
PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e35871HopAB1 contribution to virulence, and are in keeping with their
protein similarities. In support of this role for HopAB1,
HopAB2PtoDC3000 has been described to mimic HopAB1Pph1449b
promotion of virulence when expressed from a Pph 1449b lacking
HopAB1Pph1449b infecting bean resistant cultivars, and that
deletions in its C-terminal domain abolish this activity [47].
Overexpression of both HopI1Pph1448a and HopAB1Pph1448a
cause a reduction of bacterial growth in planta. Expression of these
effectors could require a tight regulation to avoid unspecific
alterations of plant processes (i.e. chloroplast activity or unspecific
ubiquitin-directed, proteasome-mediated protein degradation), or
could alter the secretion hierarchy. However, in the case of HopI1,
the slight reduction of growth that also determines in rich medium
suggests an additional toxic effect for the bacteria. A requirement
for a tight regulation of expression for some effectors is supported
by our complementation results (Figure 4; [17]). Expression of
HopAB1 and HopI1 only complements the mutant phenotypes
when expression is driven from their native promoters, and not
from PlacZ, and even in this case complementation can only be
detected at late stages of the infection, suggesting that either in trans
expression, or differences in gene dosage prevent full complemen-
tation. We also showed previously that growth attenuation of a
DavrB4-1 DavrB4-2 double mutant could not be complemented
when either AvrB4-1 or AvrB4-2 was expressed from PnptII, but
was complemented by either AvrB4-1 expression from its native
promoter, or PlacZ-driven AvrB4-2 expression.
Since three out of the four group I effectors have homologues
with demonstrated defence suppression capabilities, and both their
mutant phenotypes within the plant (Figure 3), and the protein
similarities to their homologues supports similar activities for the
Pph 1448a effectors (Figure S3), we carried out epistasis analysis to
establish their mutual functional relationships. Our results show
that HopAB1 contribution to virulence is independent from the
function of HopI1 and that of HopI1 is also independent from
HopAB1 function. Thus, we believe these effectors do contribute
to Pph 1448a virulence independently. Information available for
the virulence activities of their homologues in other pathovars does
support this notion. Reversely, HopAB1 contribution to virulence
is fully dependent on the function of HopR1, whereas that of
HopR1 is independent from HopAB1 function. These results fit a
model in which both of these effectors would contribute to
virulence by suppressing at different levels the same or related
defence pathways, in such a manner that for HopAB1-mediated
suppression to be effective, HopR1 suppression must take place.
Further analysis would be necessary to establish the molecular
basis for the functional interactions detected between these
effectors. Our results highlight the potential diversity of the
functional relationships displayed by effectors encoded by a given
pathogen. It also highlights the need to study effector function
within the context of the infection, where the virulence of a given
strain is not a simple summation of the functions performed by
each effector when individually assayed in heterologous systems,
but the complex result of their mutual functional interactions. We
also believe that this study also proves the potential that highly
sensitive virulence assays such as mixed infection-based assays (i.e.
CI and COI) have in the challenge of understanding how the
different effector activities of a given pathogen participate and
relate to determines virulence, particularly when coupled with
classical genetic analysis.
Materials and Methods
Bacterial strains and growth conditions
Bacterial strains used in this work are listed in Table 1. Pph
1448a and derivative strains were grown at 28uCi nLuria-Bertani
(LB) medium. Antibiotics were used at the following concentra-
tion: kanamycin (15 mg/ml), rifampicin (15 mg/ml), and cyclohex-
imide (2 mg/ml).
Plasmids and cloning procedures
To obtain phopAB1 and phopI1, the ORFs of hopAB1 and hopI1,
including their putative ribosome-binding site and their native
promoter, were PCR-amplified and cloned into pBBR1MCS4
[29,57], using Pph 1448a genomic DNA as a template, and the
corresponding primers (full_hopAB1-R 59-GTCGAATTCCCA-
TACGGTAATGTTGACCC-39, full_hopAB1-F 59-GTCAAG-
CTTGTCAAACAGCAACTATTGGG-39, hopI1-R 59-GTCG-
AATTCTTCTGACAGTCTCCTCACGC-39 and full_hopI1-F
59-GTCAAGCTTGCACACACCTGACTGATGC-39). To gen-
erate pPnptII::hopAB1 and pPnptII::hopI1, the ORFs of hopAB1 and
hopI1, excluding their native promoter but not their ribosome-
binding sites, were PCR-amplified and cloned into pAMEX [29]
under the control of the PnptII promoter, using Pph 1448a genomic
DNA as a template, and the corresponding primers (hopAB1-R 59-
GTCGAATTCCGATGCTCTCTTGAAAAACGG-39, hopAB1-
F5 9-GTCAAGCTTTTCGCAACCATGAGATCAGG-39, ho-
pI1-R 59- GTCGAATTCTTCTGACAGTCTCCTCACGC-39
and hopI1-F 59-GTCAAGCTTACTAGATCCCGTTGCTT-
GCC-39).s
Generation of double mutant strains
Double mutant strains (Table 1) were generated as follows.
Plasmid pFLP2, expressing the flipase enzyme, was transformed
into the corresponding single mutant strain, to promote removal of
the nptII gene by flipase-mediated site-specific recombination.
Transformants were tested in LB plates with kanamycin to identify
clones in which the kanamycin gene had been removed.
Kanamycin-sensitive isolates were then grown in LB plates
supplemented with 5% sucrose to select those that had lost the
pFLP2 vector. A second allelic exchange vector was then
transformed into the resulting kanamycin-sensitive single knockout
strain, and transformants were selected and analyzed as described
[17].
Table 3. Epistatic analysis of HopAB1 function on the contribution to virulence of HopR1 and HopI1.
Time point
Knockout effector
tested
COI (when DhopAB1 is
cancelled out) CI
COI different
from CI? COI different from 1.0?
7 dpi DhopR1 0.32+/20.003 0.24+/20.05 No Yes
7 dpi DhopI1 0.59+/20.11 0.46+/20.05 No Yes
doi:10.1371/journal.pone.0035871.t003
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growth assays
CI assays in bean plants (Phaseolus vulgaris cv. Canadian wonder)
were carried out as previously described [15]. For inoculations by
infiltration, 8-days old bean plants, grown at 22uCt o2 8 uC with a
photoperiod of 16/8 h light/dark cycle, were inoculated with
200 mlo fa5 610
4 cfu/ml mixed bacterial suspension in 10 mM
MgCl2, containing equal cfu of wild type and mutant or gene-
expressing strain, using a 1 ml syringe without needle. For
inoculations by dipping, leaves were dipped for 30 seconds in a
5610
7 cfu/ml mixed bacterial suspension in 10 mM MgCl2 and
0.02% Silwett L-77 (Crompton Europe Ltd, Evesham, UK). Serial
dilutions of the inoculum were plated onto LB agar and LB agar
with the appropriate antibiotic to confirm bacteria cfu relative
proportion between the strains, which should be close to one. At
different days post-inoculation (dpi), bacteria were recovered from
the inoculated leaves. Bacterial recovery was carried out by taking
five 10 mm-diameter discs with a cork-borer, which were
homogenized by mechanical disruption into 1 ml of 10 mM
MgCl2. Bacterial enumeration was performed by serial dilution
and plating of the samples onto agar plates with cycloheximide
and the appropriate antibiotic to differentiate the strains within the
mixed infection. For standard replication assays, the same
inoculation procedure was carried out using an individual instead
of a mixed inoculum.
Five hundred ml of a mixed inoculum at 5610
4 cfu/ml,
containing equal amounts of wild type and mutant bacteria was
inoculated into 4.5 ml of LB medium and grown for 24 h at 28uC
with aeration to determine
LBCIs. Serial dilutions were then plated
onto LB-agar and LB with the corresponding antibiotic to
calculate the relative proportion between the strains.
The CI is defined as the mutant-to-wild type ratio within the
output sample divided by the mutant-to-wild type ratio within the
input (inoculum) [58,59]. Cancelled out index (COI) was
determined using the same methodology but co-inoculating a
single with a double mutant strain. COI is defined as the double
mutant-to-single mutant ratio within the output sample divided by
the double mutant-to-single mutant ratio within the input
(inoculum) [18,44].
Competitive and cancelled out indices presented are the mean
of at least three independent experiments with three replicates per
experiment. Errors bars represent standard error. Each CI or COI
was analyzed using a homoscedastic and 2-tailed Student’s t-test
and the null hypothesis: mean index is not significantly different
from 1.0 (P value ,0.05). CI or COI comparisons were tested for
statistical significance by One Way ANOVA and Holm-Sidak test
for multiple comparison or One Way ANOVA on Ranks and
Tukey test for multiple comparison when Equal Variance Test
failed (P,0.05).
Supporting Information
Figure S1 Cancelled-out index (COI) analysis of Pph
1448a effectors HopAB1 and HopQ1. The double mutants
strains were co-infiltrated with each single mutant strain and the
corresponding COI was determined at either at 7 dpi. Each
relevant CIs is included in the figure (grey) for comparison
purposes. Each COI corresponds to the mean of at least three
independent experiments with three replicates per experiment. A
dashed line corresponding to an index value=0.5 is included for
reference. Error bars represent the standard error. Asterisks
indicate results significantly different from one, as established by
Student’s t-test (P,0.05). Mean values marked with the same letter
(a or b) indicate results not significantly different from each other,
as established by One Way ANOVA and Holm-Sidak test for
multiple comparisons (P,0.05).
(TIF)
Figure S2 Theoretical representation of COI analysis of
the interaction between two hypothetical genes, a and b.
A. CI is defined as the mutant-to-wt output ratio divided by the
mutant-to-wt input ratio. COI is defined as the double mutant-to-
single mutant output ratio divided by the double mutant-to-single
mutant input ratio. B. Determination and analysis of COI. A mix
inoculum containing an equal bacterial number of double and
single mutant stains is infiltrate into plant leaves. Bacteria are
recovered from plant leaves 4, 7 or 14 days post inoculation (dpi),
and plated into LB and LB supplemented with antibiotics, to
differentiate double and single mutants. I and II represent two
possible outcomes for the analysis. CI
a is a CI of a strain carrying a
mutation in gene a co-inoculated with the wt strain. COI
a is a COI
of a strain carrying a mutation in gene b co-inoculated with the
double mutant strain.
(TIF)
Figure S3 Sequence analysis of effectors HopAB1 and
HopI1. A. Comparison of HopAB1Pph1448a and AvrPtoBP-
toDC3000 amino acid sequences. Identical amino acids are
highlighted in blue. Sequences display 55% overall identity, while
the C-terminal region predicted to comprise the E3 ligase domain
(Pfam ID: PF09046, underlined), displays 77% identity. Position of
conserved prolines (AvrPtoBPro533, HopAB1Pro519) and large
hydrophobic residues (AvrPtoBPhe479, Phe525, HopAB1Phe465,
Tyr511) described as essential for E3 ligases [51] are marked by
red arrows. B. Comparison of Pph 1448a and Pma ES4326 HopI1
amino acid sequences. Identical amino acids are highlighted in
blue. Predicted J domain (Pfam ID: PF00226; Prosite ID:
PS50076) is underlined. Sequences display 68% overall identity.
(TIF)
Table S1 Numerical values corresponding for the CIs and COIs
displayed in figure 3, 4, 5, 6, 7 and S1.
(DOC)
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